Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/FRAZIER-LIFESCIENCES-ACQU-118740031/news/NewAmsterdam-Pharma-Debuts-as-Publicly-Traded-Company-Focused-on-Developing-Obicetrapib-a-Low-Dose-42395428/?utm_source=whatsapp&utm_medium=social&utm_campaign=share